BCL11A and sickle cell disease: CRISPR has been used to knockdown the PCSK9 gene in primates to lower the level of cholesterol53, and the editing of the BCL11A gene to treat transfusion-dependent β-thalassemia and sickle cell disease are in clinical trials54.